Related Experiment Video
Updated: Jul 11, 2026
16:57
MALDI Imaging Mass Spectrometry of Neuropeptides in Parkinson's Disease
Published on: February 14, 2012
Update on Molecular Imaging in Parkinson's Disease
Zhen-Yang Liu1, Feng-Tao Liu1, Chuan-Tao Zuo2
1Department of Neurology and National Clinical Research Center for Ageing and Medicine, Huashan Hospital, Fudan University, Shanghai, 200040, China.
Neuroscience Bulletin
|December 29, 2017
Summary
Molecular brain imaging advances Parkinson's disease (PD) diagnosis and treatment monitoring. Future research will combine imaging modalities and complex algorithms for deeper insights into PD.
Area of Science:
- Neuroimaging
- Molecular Biology
- Neurology
Background:
- Radionuclide tracers enable precise imaging of neurotransmitters, metabolism, inflammation, and protein aggregation in the brain.
- Molecular brain imaging has significantly enhanced the understanding of brain function in Parkinson's disease (PD).
Purpose of the Study:
- To highlight the role of molecular imaging in improving Parkinson's disease diagnosis.
- To discuss the application of molecular imaging in assessing therapeutic outcomes and disease progression.
- To explore the potential of molecular imaging in detecting preclinical or prodromal Parkinson's disease.
Main Methods:
- Utilizing advanced radionuclide tracers for detailed brain imaging.
- Applying molecular imaging techniques to study neurotransmitter activity, energy metabolism, inflammation, and protein accumulation.
- Leveraging imaging data for PD diagnosis and treatment evaluation.
Main Results:
- Molecular imaging provides accurate insights into various brain functions relevant to PD.
- The technology supports more precise diagnosis and monitoring of disease progression and treatment response.
- Molecular imaging is effective in identifying early-stage or preclinical Parkinson's disease.
Conclusions:
- Molecular imaging has revolutionized the study and management of Parkinson's disease.
- Future research directions involve integrating multi-modal imaging (PET/MRI) and advanced computational modeling.
- Continued advancements promise deeper understanding and improved patient outcomes in PD.
Related Concept Videos
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:25Imaging Studies II: Positron Emission Tomography and Scintigraphy
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Fundamental Principles of PET
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...